Vg Life Sciences Stock Analysis
Vg Life's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Vg Life's financial risk is the risk to Vg Life stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Vg Life's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Vg Life is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Vg Life to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Vg Life is said to be less leveraged. If creditors hold a majority of Vg Life's assets, the Company is said to be highly leveraged.
Vg Life Sciences is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Vg Life pink sheet analysis is to determine its intrinsic value, which is an estimate of what Vg Life Sciences is worth, separate from its market price. There are two main types of Vg Life's stock analysis: fundamental analysis and technical analysis.
The Vg Life pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
VGLS |
VGLS Pink Sheet Analysis Notes
The company recorded a loss per share of 0.07. Vg Life Sciences had not issued any dividends in recent years. The entity had 1:600 split on the 27th of November 2012. VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. VG Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.The quote for Vg Life Sciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call the company at 805 879 9000 or visit https://www.vglifesciences.com.Vg Life Sciences Investment Alerts
| Vg Life Sciences is way too risky over 90 days horizon | |
| Vg Life Sciences has some characteristics of a very speculative penny stock | |
| Vg Life Sciences appears to be risky and price may revert if volatility continues | |
| Vg Life Sciences currently holds 3.38 M in liabilities. Vg Life Sciences has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vg Life until it has trouble settling it off, either with new capital or with free cash flow. So, Vg Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vg Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VGLS to invest in growth at high rates of return. When we think about Vg Life's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vg Life Sciences currently holds about 22.92 K in cash with (1.91 M) of positive cash flow from operations. |
VGLS Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vg Life's market, we take the total number of its shares issued and multiply it by Vg Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Compared to fundamental indicators, the technical analysis model makes it possible for you to check helpful technical drivers of Vg Life Sciences, as well as the relationship between them.Vg Life Sciences Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Vg Life Sciences price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
Vg Life Outstanding Bonds
Vg Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vg Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most VGLS bonds can be classified according to their maturity, which is the date when Vg Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US918204AT53 Corp BondUS918204AT53 | View | |
| V F P Corp BondUS918204AR97 | View | |
| VF PORATION Corp BondUS918204BC10 | View | |
| US918204BB37 Corp BondUS918204BB37 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Vg Life Sciences Debt to Cash Allocation
Many companies such as Vg Life, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Vg Life Sciences currently holds 3.38 M in liabilities. Vg Life Sciences has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vg Life until it has trouble settling it off, either with new capital or with free cash flow. So, Vg Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vg Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VGLS to invest in growth at high rates of return. When we think about Vg Life's use of debt, we should always consider it together with cash and equity.Vg Life Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Vg Life's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Vg Life, which in turn will lower the firm's financial flexibility.Vg Life Corporate Bonds Issued
About VGLS Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Vg Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling VGLS shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Vg Life. By using and applying VGLS Pink Sheet analysis, traders can create a robust methodology for identifying VGLS entry and exit points for their positions.
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. VG Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Vg Life to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Additional Tools for VGLS Pink Sheet Analysis
When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.